Bristol-Myers Squibb (Canada)
Parent institution Bristol-Myers Squibb (United States)
ROR: Yes
Works count: 181
Citations count: 4,451
Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
2013 · Roger S. McIntyre, Marie‐Josée Filteau, et al. · Journal of Affective Disorders
Multicenter Phase III Study of Uracil/Tegafur and Oral Leucovorin Versus Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer
2002 · Jean‐Yves Douillard, Paulo M. Hoff, et al. · Journal of Clinical Oncology
Randomized Comparative Study of Tegafur/Uracil and Oral Leucovorin Versus Parenteral Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer
2002 · James Carmichael, T Popiela, et al. · Journal of Clinical Oncology